Funding: This study was funded by a NH&MRC project grant.
Screening for colorectal cancer by faecal occult blood test: why people choose to refuse
Article first published online: 3 AUG 2006
2006 Royal Australasian College of Physicians
Internal Medicine Journal
Volume 36, Issue 9, pages 607–610, September 2006
How to Cite
Worthley, D. L., Cole, S. R., Esterman, A., Mehaffey, S., Roosa, N. M., Smith, A., Turnbull, D. and Young, G. P. (2006), Screening for colorectal cancer by faecal occult blood test: why people choose to refuse. Internal Medicine Journal, 36: 607–610. doi: 10.1111/j.1445-5994.2006.01155.x
Potential conflicts of interest: Professor Young reports having received research funds and consulting fees from Enterix.
- Issue published online: 3 AUG 2006
- Article first published online: 3 AUG 2006
- Received 5 October 2005; accepted 9 February 2006.
- colonic neoplasm;
- occult blood;
- mass screening;
- multiphasic screening;
- patient participation
To better understand the personal barriers that limit participation in faecal occult blood test (FOBT) screening for colorectal cancer, non-participants from a recent screening initiative were sent detailed questionnaires, defining their reasons for not participating, as well as how to make screening more attractive. The important barrier was procrastination. The type of FOBT kit offered influenced the reasons for not participating. Convenient FOBT and greater general practitioner involvement may be important for optimizing community acceptance of FOBT-based screening.